Supporting Document 1: References

1. World Health Organization. (2023). Dementia. https://www.who.int/news-room/fact-sheets/detail/dementia 
2. Mauricio, R., Benn, C., Davis, J., et al.  (2019). Tackling gaps in developing life-changing treatments for dementia. Alzheimer's & dementia (New York, N. Y.), 5, 241–253. https://doi.org/10.1016/j.trci.2019.05.001
3. Zhang, J., Zhang, Y., Wang, J., et al. (2024). Recent advances in Alzheimer’s disease: mechanisms, clinical trials and new drug development strategies. Signal Transduction and Targeted Therapy 9, 211. https://doi.org/10.1038/s41392-024-01911-3
4. Ali, M., Rizvi, S. & Syed, B. (2017). Trends in the market for antihypertensive drugs. Nature Reviews Drug Discovery 16, 309–310. https://doi.org/10.1038/nrd.2016.262
5. Yaghmaei, E., Lu, H., Ehwerhemuepha, L., et al. (2024). Combined use of Donepezil and Memantine increases the probability of five-year survival of Alzheimer’s disease patients. Communications Medicine 4, 99. https://doi.org/10.1038/s43856-024-00527-6
6. Cheng, F., Kovács, I.A. & Barabási, AL. (2019). Network-based prediction of drug combinations. Nature Communications 10, 1197. https://doi.org/10.1038/s41467-019-09186-x
7. Srinivasan, S. (2022). Comprehensive Human PPI Network and TF Network (v1.0.1) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.7311831
8. Yépez, V. A., Smith, N. H., Mertes, C., et al. (2022). Gene expression and splicing counts from 49 tissues from GTEx v8 genome build hg38 - non-strand specific (1.0) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.6078397
9. O'Sullivan C., Stahl K., Stevenson J., et al. (2024). dgidb/dgidb-v5: v.5.0.7 (v.5.0.7). Zenodo. https://doi.org/10.5281/zenodo.11521558
10. Etkin A., Segal D., Ferreira da Silva M., Blake L. (2023). Enhancement of cAMP signaling as a combination drug strategy for the treatment of psychiatric and neurological disorders in which depressive, anhedonia, motivation-related or cognition-related dysfunction exists. Patent No. US2023/0117508 A1. The full text is available in Supportunity Document 3. 
11. Thieurmel B. (2022). Introduction to visNetwork. CRAN R Project Repository. https://cran.r-project.org/web/packages/visNetwork/vignettes/Introduction-to-visNetwork.html 
12. Clinical Trials Transformation Initiative. (2024). Clinical Trials Transformation Initiative's (CTTI) Trial Information through September 2024 (20240927_export_ctgov) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.13984069
13. Posit. (2024) Shinyapps.io by Posit. https://www.shinyapps.io/. Also, a beginning draft of the DRAGON platform is in Supporting Document 4.
14. Kabir, M. T., Uddin, M. S., Mamun, A. A., et al. (2020). Combination Drug Therapy for the Management of Alzheimer's Disease. International journal of molecular sciences, 21(9) , 3272. https://doi.org/10.3390/ijms21093272
15. Regan, M. M., Gelber, R. D., & International Breast Cancer Study Group (IBCSG) and the Breast International Group (BIG). (2007). Using clinical trial data to tailor adjuvant treatments for individual patients. Breast (Edinburgh, Scotland), 16 Suppl 2(Suppl 2), S98–S104. https://doi.org/10.1016/j.breast.2007.07.016
16. Alves, V. M., Korn, D., Pervitsky, V., et al.  (2022). Knowledge-based approaches to drug discovery for rare diseases. Drug discovery today, 27(2), 490–502. https://doi.org/10.1016/j.drudis.2021.10.014
17. Blischak JD, Carbonetto P & Stephens M. (2019). Creating and sharing reproducible research code the workflowr way [version 1; peer review: 3 approved]. F1000Research, 8:1749. https://doi.org/10.12688/f1000research.20843.1
18. Polsky Center I-Corps Program. (2024). Polsky Center. https://polsky.uchicago.edu/programs-events/polsky-i-corps/ 
19. Soliai M. (2024). Msoliai’s Github repository. https://github.com/msoliai. 
20. Blake, L. (2021). Regulatory Evolution in Primates. Github. https://github.com/Lauren-Blake/Regulatory_Evol 
21. Blake, L. (2021). Regulatory Evolution in Primates. Github.io. https://lauren-blake.github.io/Regulatory_Evol/analysis/
